Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Grace A. Martin, PharmD, BCOP
Authored Items
Outcomes of Pharmacist-Provided Telehealth Services in an Ambulatory Oncology Clinic During the COVID-19 Pandemic
Colleen Bohnenkamp, PharmD, BCOP, BCPS
,
Grace A. Martin, PharmD, BCOP
,
Laure DuBois, PharmD, BCOP
,
Olivia Fahey, PharmD, BCOP
,
Jade Hefler, PharmD
JHOP - October 2021 Vol 11, No 5
in
Original Article
,
Telehealth
,
COVID-19
Safety of Inactivated Vaccines in Patients Receiving Immune Checkpoint Inhibitors
Austin Kurkowski, PharmD, BCOP
,
Grace A. Martin, PharmD, BCOP
,
Shelbie Ralph, PharmD, BCOP
,
Zahra Mahmoudjafari, PharmD, BCOP
,
Dennis Grauer, PhD, MS
,
Elizabeth Wulff-Burchfield, MD
JHOP - August 2021 Vol 11, No 4
in
Original Article
,
Vaccinations
,
Checkpoint Inhibitors
Last modified: August 17, 2021